Clinical impact of HSD3B1 polymorphism by metastatic volume and somatic HSD3B1 alterations in advanced prostate cancer.
Shiota M, Fujimoto N, Sekino Y, Tsukahara S, Nagakawa S, Takamatsu D, Abe T, Kinoshita F, Ueda S, Ushijima M, Matsumoto T, Kashiwagi E, Inokuchi J, Uchiumi T, Oda Y, Eto M.
Shiota M, et al. Among authors: fujimoto n.
Andrologia. 2022 Feb;54(1):e14307. doi: 10.1111/and.14307. Epub 2021 Nov 8.
Andrologia. 2022.
PMID: 34747051